BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 22035194)

  • 1. ATM and the molecular pathogenesis of ataxia telangiectasia.
    McKinnon PJ
    Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia and related diseases.
    Frappart PO; McKinnon PJ
    Neuromolecular Med; 2006; 8(4):495-511. PubMed ID: 17028372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia.
    Rimkus SA; Katzenberger RJ; Trinh AT; Dodson GE; Tibbetts RS; Wassarman DA
    Genes Dev; 2008 May; 22(9):1205-20. PubMed ID: 18408079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells.
    Biton S; Dar I; Mittelman L; Pereg Y; Barzilai A; Shiloh Y
    J Biol Chem; 2006 Jun; 281(25):17482-17491. PubMed ID: 16627474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of ataxia telangiectasia and related diseases.
    Ball LG; Xiao W
    Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.
    Iwahori S; Shirata N; Kawaguchi Y; Weller SK; Sato Y; Kudoh A; Nakayama S; Isomura H; Tsurumi T
    J Virol; 2007 Sep; 81(18):9653-64. PubMed ID: 17609267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
    Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
    Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The innate immune response transcription factor relish is necessary for neurodegeneration in a Drosophila model of ataxia-telangiectasia.
    Petersen AJ; Katzenberger RJ; Wassarman DA
    Genetics; 2013 May; 194(1):133-42. PubMed ID: 23502677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM and ataxia telangiectasia.
    McKinnon PJ
    EMBO Rep; 2004 Aug; 5(8):772-6. PubMed ID: 15289825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
    Yang DQ; Halaby MJ; Li Y; Hibma JC; Burn P
    Drug Discov Today; 2011 Apr; 16(7-8):332-8. PubMed ID: 21315178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
    Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
    Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
    Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the ataxia telangiectasia mutated-mediated DNA damage response in murine cerebellar neurons.
    Dar I; Biton S; Shiloh Y; Barzilai A
    J Neurosci; 2006 Jul; 26(29):7767-74. PubMed ID: 16855104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM dependent apoptosis in the nervous system.
    Lee Y; McKinnon PJ
    Apoptosis; 2000 Dec; 5(6):523-9. PubMed ID: 11303911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death.
    Tian B; Yang Q; Mao Z
    Nat Cell Biol; 2009 Feb; 11(2):211-8. PubMed ID: 19151707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain and induced pluripotent stem cell-derived neural stem cells as an in vitro model of neurodegeneration in ataxia-telangiectasia.
    Carlessi L; Fusar Poli E; Delia D
    Exp Biol Med (Maywood); 2013 Mar; 238(3):301-7. PubMed ID: 23598976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.
    Jacquemin V; Rieunier G; Jacob S; Bellanger D; d'Enghien CD; Laugé A; Stoppa-Lyonnet D; Stern MH
    Eur J Hum Genet; 2012 Mar; 20(3):305-12. PubMed ID: 22071889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.